Scientists discover why ozempic may not work for some people
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance."...
schedule
15:13 visibility
80 views
Source: Science Daily
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications.
Kenya has recorded a second Ebola death, the health ministry said late Friday. The 65-year-old woman had developed symptoms during quarantine and was a close relative of a Kenyan man who died of the disease.
Hosted by TechCrunch in partnership with Fidelity Private Shares, the full-day event goes beyond fundraising and AI to explore the realities of finding customers, building teams, sharpening a pitch, developing founder leadership, and scaling...
Switzerland says patient is wife of Swiss diplomat and believed to have contracted virus while travelling in UgandaHealth officials across Africa are racing to determine how Nigeria’s first Ebola patient in more than a decade became infected, amid...
When we published our review of the iPhone Duo, I got a lot of hopeful questions from my fellow Mini fans who took note of the cover screen's Mini-ish 5.4-inch size. "Is this… a small phone that turns into a tablet?" they asked. And I'm sorry to be...
Jean-Emile Jammine is pleased to welcome Gökçe Tuncel, Sociologist and post-doctoral researcher associated with the Université Paris-Est Créteil (UPEC). For Tuncel, the wave of youth-led protests across France, Albania, India and Italy reveals more...
An admirably dark and wince-inducing detour for DC Studios, who get a lot right with 'Clayface' when it comes to horror. However, the script lets it down in the second half, leading to a bold but uneven result.
Euronews
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more